However, patients showing a loss of SMAD4 expression in their tumor tissue had a statistically significantly longer PFS than patients with preserved SMAD4 expression (median 7.0 vs. 5.8 months, p = 0.038, Figure 2B, Table 2). This evidence concerns the gene SMAD4 and neoplasm.